±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 587  |  »Ø¸´: 6
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

yelverxm

½ð³æ (СÓÐÃûÆø)

[½»Á÷] Çó½Ì¸ßάQSAR

¸Õ·¢ÏÖ¼ÆËã»úÄ£ÄâµÄ°å¿é£¬Ò©ÎïÉè¼Æ°æÃ澹ȻûÓÐÌù°¡¡£

ÎҾͷ¢¸öÎÊÌâÇë½Ìϸ÷λ¸ßÊÖ°É

±¾ÈË×î½üÕýÔÚѧϰ4DQSAR£¬µ«ÊÇÖ÷ÒªÏëÀûÓÃ4DµÄ¼¼Êõ×ö¸öQSPRÄ£ÐÍ£¬µ«²»ÖªµÀ²ÉÑùµÄÄÇЩ³ÌÐòÓÐÏֳɵĿÉÀûÓõÄÂð£¿

Èç¹ûÏÖ±àµÄ»°£¬±¾ÈË»¹ÊÇÓÐÒ»¶¨À§ÄѵĆª
»Ø¸´´ËÂ¥
In God we trust
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yalefield

½ð³æ (ÎÄ̳¾«Ó¢)

ÀϺºÒ»Ã¶

ºÇºÇ£¬5D QSAR¶¼ÒѾ­³öÀ´à¶

¡ï
zzgyb(½ð±Ò+1,VIP+0):ллÄãµÄ²ÎÓ룬ϣÍû¼ÌÐø¹Ø×¢¼ÆËãÄ£Äâ°æ
Sylvie Ducki, Grant Mackenzie, Nicholas J. Lawrence, and James P. Snyder
Quantitative Structure-Activity Relationship (5D-QSAR) Study of Combretastatin-like Analogues as Inhibitors of Tubulin Assembly
J. Med. Chem., 48 (2), 457-465, 2005.

Vedani A, Dobler M.
5D-QSAR: the key for simulating induced fit?
J Med Chem. 2002. 45(11):2139-2149

Vedani A, Dobler M, Dollinger H, Hasselbach KM, Birke F, Lill MA.
Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR.
J Med Chem. 2005. 48(5):1515-1527
5Â¥2007-12-10 22:11:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 7 ¸ö»Ø´ð

luai071

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сºì¶¹(½ð±Ò+1,VIP+0):¸Ðл·ÖÏí£¡ÐÁ¿àÁË£¡
¸ßάµÄQSARÎÒÈÏΪºÜ´ó³Ì¶ÈÉÏ»¹ÊǸÅÄîÐԵģ¬Ã»Óеõ½È«ÃæÈÏ¿ÉºÍÆÕ±éÓ¦Óã¬Èç¹ûÏëÕÒÒÑÓеÄËã·¨»ò³ÌÐòµÄ»°£¬¿ÉÒÔ´Ó²éÔÄÎÄÏ×ÈëÊÖ¡£
2Â¥2007-12-07 12:21:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yelverxm

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
Originally posted by luai071 at 2007-12-7 12:21:
¸ßάµÄQSARÎÒÈÏΪºÜ´ó³Ì¶ÈÉÏ»¹ÊǸÅÄîÐԵģ¬Ã»Óеõ½È«ÃæÈÏ¿ÉºÍÆÕ±éÓ¦Óã¬Èç¹ûÏëÕÒÒÑÓеÄËã·¨»ò³ÌÐòµÄ»°£¬¿ÉÒÔ´Ó²éÔÄÎÄÏ×ÈëÊÖ¡£

ÎÒÒ²¾õµÃ¸ßάQSARûÓеõ½¹ã·ºÈÏͬ£¬ÏëHopfingerÌá³ö4DQSARÖ®ºó£¬·¢µÄ20¶àƪÎÄÕ¾ø´ó²¿·Ö»¹ÊÇËû×Ô¼ºÐ´µÄ¡­¡­

µ«ÊÇÎÒ¾õµÃÆä×÷ΪһÖÖ½â¾ö¹¹ÏóÃô¸ÐµÄ·½·¨£¬¿ÉÒÔÊÔÏ¡£

»¹µÃ¿´ÂÛÎÄȥѽ^^
In God we trust
3Â¥2007-12-08 02:11:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)

Êǰ¡£¬Ç°Ñض«Î÷Ò»¶¨µÃ¿¿×Ôѧ£¬ÍùÍù¡°È¨Íþ¡±Ò²²»¶®
4Â¥2007-12-10 14:22:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] µ÷¼ÁÇóÖú +10 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 13/650 2026-04-05 09:41 by sam3303
[¿¼ÑÐ] Çóµ÷¼Á +10 ÐܶþÏëÉϰ¶ 2026-04-04 10/500 2026-04-05 08:09 by qlm5820
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ìµ÷¼Á +19 ÉîVËÞÉá°É 2026-03-30 20/1000 2026-04-04 22:13 by hemengdong
[¿¼ÑÐ] 283·ÖÇóµ÷¼Á +7 СÄô°®Ñ§Ï° 2026-04-03 7/350 2026-04-04 21:51 by hemengdong
[¿¼ÑÐ] µ÷¼Á +4 ÊÇ¿ÉÀÖ²»ÊÇ¿ÉÀÖ 2026-04-04 4/200 2026-04-04 19:41 by ÌÆãå¶ù
[¿¼ÑÐ] 291Çóµ÷¼Á +4 ÃÔÃÉľľ 2026-04-01 5/250 2026-04-04 15:59 by sihailian3
[¿¼ÑÐ] 320Çóµ÷¼Á +5 Õñ¡ªTZ 2026-04-02 5/250 2026-04-03 14:42 by fxue1114
[¿¼ÑÐ] 08¹¤¿Æ275·ÖÇóµ÷¼Á +14 AaAa7420 2026-03-31 14/700 2026-04-03 11:13 by cocolv
[¿¼ÑÐ] Ò»Ö¾Ô¸Öйú¿ÆÑ§Ôº´óѧ265Çóµ÷¼Á +9 Ìñµ­ye 2026-03-31 10/500 2026-04-03 11:10 by txp1986
[¿¼ÑÐ] Ò»Ö¾Ô¸´ó¹¤Ñ§Ë¶£¬Çóµ÷¼Á +4 yub0811 2026-04-02 4/200 2026-04-02 21:36 by °ÙÁéͯ888
[¿¼²©] ²ÄÁϹ¤³Ìרҵ˶ʿÉ격 +3 ÷ëÕýÓî 2026-03-30 3/150 2026-04-02 15:04 by greychen00
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-04-02 4/200 2026-04-02 13:03 by yulian1987
[¿¼ÑÐ] 311Çóµ÷¼Á +14 À¶ÔÂÁÁÁÁ 2026-03-30 14/700 2026-04-02 12:18 by 1753564080
[¿¼ÑÐ] 266·Ö£¬Ò»Ö¾Ô¸µçÆø¹¤³Ì£¬±¾¿Æ²ÄÁÏ£¬Çó²ÄÁÏרҵµ÷¼Á +10 ÍÛºôºßºôºß 2026-04-01 11/550 2026-04-02 11:31 by lnilvy
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-04-02 4/200 2026-04-02 09:52 by yulian1987
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©Ê¦·¶´óѧ¼ÆËã»úר˶£¬³õÊÔ373£¬Áù¼¶Í¨¹ý£¬ +3 ¼ÆËã»ú×·ÃÎÈË 2026-04-01 3/150 2026-04-02 07:57 by fxue1114
[¿¼ÑÐ] 0710ÉúÎïѧÇóµ÷¼Á£¡ +6 ÐðÊöÎÄ 2026-03-31 6/300 2026-04-01 09:39 by JourneyLucky
[¿¼ÑÐ] 085601Ó¢¶þÊý¶þÇóµ÷¼Á ×Ü·Ö325 +4 Óຽº½ 2026-03-31 4/200 2026-03-31 17:38 by ÌÆãå¶ù
[¿¼ÑÐ] 080500-315·Ö¸´ÊÔµ÷¼Á +9 Éϰ¶3821 2026-03-31 9/450 2026-03-31 17:29 by ÌÆãå¶ù
[Óлú½»Á÷] ¼×»ùÑǻǻÇËáÄÆºÍ¼×»ù»ÇËáõ¥·´Ó¦»úÀí 10+3 kaobao456 2026-03-29 4/200 2026-03-30 23:16 by nBuï®
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û